Heier S. Jeffrey's most recent trade in Ocular Therapeutix Inc was a trade of 3,057 Common Stock done at an average price of $8.3 . Disclosure was reported to the exchange on Feb. 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc | Jeffrey S. Heier | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.28 per share. | 23 Feb 2026 | 3,057 | 323,368 (0%) | 0% | 8.3 | 25,312 | Common Stock |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 240,932 | 240,932 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 79,112 | 326,425 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.04 per share. | 24 Nov 2025 | 3,469 | 245,940 (0%) | 0% | 12.0 | 41,767 | Common Stock |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.04 per share. | 02 Oct 2025 | 10,502 | 249,409 (0%) | 0% | 11.0 | 115,942 | Common Stock |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.04 per share. | 25 Aug 2025 | 3,063 | 259,911 (0%) | 0% | 12.0 | 36,879 | Common Stock |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.18 per share. | 23 May 2025 | 3,024 | 262,974 (0%) | 0% | 7.2 | 21,712 | Common Stock |
| Ocular Therapeutix Inc | Heier S. Jeffrey | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.87 per share. | 24 Feb 2025 | 3,061 | 265,998 (0%) | 0% | 6.9 | 21,029 | Common Stock |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 25 Nov 2024 | 2,948 | 269,059 (0%) | 0% | 9.0 | 26,561 | Common Stock |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 100,000 | 272,007 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 17,350 | 17,350 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,000 | 59,933 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,933 | 47,933 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Director | Purchase of securities on an exchange or from another person at price $ 3.05 per share. | 12 May 2022 | 15,000 | 39,000 (0%) | 0% | 3.1 | 45,750 | Common Stock |
| Ocular Therapeutix Inc | Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) |